KIF2C and prostate adenocarcinoma: Using the TCGA prostate adenocarcinoma (PRAD) dataset, patients were divided into high and low expression groups based on the median value of KIF2C expression to see if there was an association between KIF2C expression and PCa clinicopathological features.